281 related articles for article (PubMed ID: 34526064)
1. Plasma inflammatory cytokines and treatment-resistant depression with comorbid pain: improvement by ketamine.
Zhou Y; Wang C; Lan X; Li H; Chao Z; Ning Y
J Neuroinflammation; 2021 Sep; 18(1):200. PubMed ID: 34526064
[TBL] [Abstract][Full Text] [Related]
2. Antidepressant Effect of Ketamine on Inflammation-Mediated Cytokine Dysregulation in Adults with Treatment-Resistant Depression: Rapid Systematic Review.
Sukhram SD; Yilmaz G; Gu J
Oxid Med Cell Longev; 2022; 2022():1061274. PubMed ID: 36160713
[TBL] [Abstract][Full Text] [Related]
3. Alterations of multiple peripheral inflammatory cytokine levels after repeated ketamine infusions in major depressive disorder.
Zhan Y; Zhou Y; Zheng W; Liu W; Wang C; Lan X; Deng X; Xu Y; Zhang B; Ning Y
Transl Psychiatry; 2020 Jul; 10(1):246. PubMed ID: 32699226
[TBL] [Abstract][Full Text] [Related]
4. Change in cytokine levels is not associated with rapid antidepressant response to ketamine in treatment-resistant depression.
Park M; Newman LE; Gold PW; Luckenbaugh DA; Yuan P; Machado-Vieira R; Zarate CA
J Psychiatr Res; 2017 Jan; 84():113-118. PubMed ID: 27718369
[TBL] [Abstract][Full Text] [Related]
5. Rapid inflammation modulation and antidepressant efficacy of a low-dose ketamine infusion in treatment-resistant depression: A randomized, double-blind control study.
Chen MH; Li CT; Lin WC; Hong CJ; Tu PC; Bai YM; Cheng CM; Su TP
Psychiatry Res; 2018 Nov; 269():207-211. PubMed ID: 30153598
[TBL] [Abstract][Full Text] [Related]
6. Repeated intravenous infusions of ketamine: Neurocognition in patients with anxious and nonanxious treatment-resistant depression.
Liu W; Zhou Y; Zheng W; Wang C; Zhan Y; Lan X; Zhang B; Li H; Chen L; Ning Y
J Affect Disord; 2019 Dec; 259():1-6. PubMed ID: 31430662
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic and Safety Outcomes of Intravenous Ketamine for Treatment-refractory Depression in a Veteran Population: A Case Series.
Vitek G; Langenfeld R; Walters RW; Elson A; Driscoll D; Ramaswamy S
Mil Med; 2023 Jul; 188(7-8):e2242-e2248. PubMed ID: 36539918
[TBL] [Abstract][Full Text] [Related]
8. Altered peripheral immune profiles in treatment-resistant depression: response to ketamine and prediction of treatment outcome.
Kiraly DD; Horn SR; Van Dam NT; Costi S; Schwartz J; Kim-Schulze S; Patel M; Hodes GE; Russo SJ; Merad M; Iosifescu DV; Charney DS; Murrough JW
Transl Psychiatry; 2017 Mar; 7(3):e1065. PubMed ID: 28323284
[TBL] [Abstract][Full Text] [Related]
9. Neurocognitive performance of repeated versus single intravenous subanesthetic ketamine in treatment resistant depression.
Shiroma PR; Thuras P; Wels J; Albott CS; Erbes C; Tye S; Lim KO
J Affect Disord; 2020 Dec; 277():470-477. PubMed ID: 32871534
[TBL] [Abstract][Full Text] [Related]
10. Ketamine's antidepressant efficacy is extended for at least four weeks in subjects with a family history of an alcohol use disorder.
Niciu MJ; Luckenbaugh DA; Ionescu DF; Richards EM; Vande Voort JL; Ballard ED; Brutsche NE; Furey ML; Zarate CA
Int J Neuropsychopharmacol; 2014 Oct; 18(1):. PubMed ID: 25539512
[TBL] [Abstract][Full Text] [Related]
11. Functional changes in sleep-related arousal after ketamine administration in individuals with treatment-resistant depression.
Ballard ED; Greenstein D; Reiss PT; Crainiceanu CM; Cui E; Duncan WC; Hejazi NS; Zarate CA
Transl Psychiatry; 2024 Jun; 14(1):238. PubMed ID: 38834540
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of low-dose ketamine infusion in anxious vs nonanxious depression: revisiting the Adjunctive Ketamine Study of Taiwanese Patients with Treatment-Resistant Depression.
Chen MH; Lin WC; Wu HJ; Bai YM; Li CT; Tsai SJ; Hong CJ; Tu PC; Cheng CM; Su TP
CNS Spectr; 2021 Aug; 26(4):362-367. PubMed ID: 32419678
[TBL] [Abstract][Full Text] [Related]
13. Strategies to Prolong Ketamine's Efficacy in Adults with Treatment-Resistant Depression.
McMullen EP; Lee Y; Lipsitz O; Lui LMW; Vinberg M; Ho R; Rodrigues NB; Rosenblat JD; Cao B; Gill H; Teopiz KM; Cha DS; McIntyre RS
Adv Ther; 2021 Jun; 38(6):2795-2820. PubMed ID: 33929660
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Early Ketamine Effects on Belief-Updating Biases in Patients With Treatment-Resistant Depression.
Bottemanne H; Morlaas O; Claret A; Sharot T; Fossati P; Schmidt L
JAMA Psychiatry; 2022 Nov; 79(11):1124-1132. PubMed ID: 36169969
[TBL] [Abstract][Full Text] [Related]
15. Association between peripheral biomarkers and clinical response to IV ketamine for unipolar treatment-resistant depression: An open label study.
Kang MJY; Vazquez GH
J Affect Disord; 2022 Dec; 318():331-337. PubMed ID: 36070831
[TBL] [Abstract][Full Text] [Related]
16. Cytokine- and Vascular Endothelial Growth Factor-Related Gene-Based Genome-Wide Association Study of Low-Dose Ketamine Infusion in Patients with Treatment-Resistant Depression.
Tsai SJ; Kao CF; Su TP; Li CT; Lin WC; Hong CJ; Bai YM; Tu PC; Chen MH
CNS Drugs; 2023 Mar; 37(3):243-253. PubMed ID: 36763263
[TBL] [Abstract][Full Text] [Related]
17. Association of Neurofilament Light Chain With the Antidepressant Effects of Low-Dose Ketamine Infusion Among Patients With Treatment-Resistant Depression.
Lin WC; Su TP; Li CT; Wu HJ; Bai YM; Liu YL; Tu PC; Chen MH
Int J Neuropsychopharmacol; 2023 Sep; 26(9):649-653. PubMed ID: 37490687
[TBL] [Abstract][Full Text] [Related]
18. Efficacy, Safety, and Durability of Repeated Ketamine Infusions for Comorbid Posttraumatic Stress Disorder and Treatment-Resistant Depression.
Albott CS; Lim KO; Forbes MK; Erbes C; Tye SJ; Grabowski JG; Thuras P; Batres-Y-Carr TM; Wels J; Shiroma PR
J Clin Psychiatry; 2018; 79(3):. PubMed ID: 29727073
[TBL] [Abstract][Full Text] [Related]
19. Whole blood transcriptional signatures associated with rapid antidepressant response to ketamine in patients with treatment resistant depression.
Cathomas F; Bevilacqua L; Ramakrishnan A; Kronman H; Costi S; Schneider M; Chan KL; Li L; Nestler EJ; Shen L; Charney DS; Russo SJ; Murrough JW
Transl Psychiatry; 2022 Jan; 12(1):12. PubMed ID: 35013133
[TBL] [Abstract][Full Text] [Related]
20. [Ketamine's antidepressant effect: literature review on clinical use].
De Maricourt P; Jay T; Goncalvès P; Lôo H; Gaillard R
Encephale; 2014 Feb; 40(1):15-23. PubMed ID: 24434008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
